The different pathologies that are targeted by GenSodi, share the use of cytokines as curative molecules or links with inflammatory responses.
Predictive Medicine explores one of the newest, most exciting developments in medicine today. The paradigm shifts from medicine as the treatment of disease, to medicine as the true prevention of illness. To face such challenge, it is crucial to produce and analyze huge amount of clinical and biological data in order to identify specific biological markers to monitor the response to treatment or to evaluate the efficiency of therapeutic drugs. Moreover, the patient's genetic makeup and the related genetic markers can be the springboard to either prevent occurrence of a disease, or to personalize treatment according to the patient's genotype.
GenSodi intends to bring to the market novel diagnostic products for major inflammatory diseases, as reliable and non-invasive. These products are based on the analysis of expression profiles of CIGsearch™ Gene Arrays. Data are collected and analyzed in the course of medical research programs performed in collaboration with several famous medical centers. Depending on the nature of the selected markers (detection of genes or proteins), Gensodi is developing different types of kits for early diagnostic as well as for therapy responses providing better assessment of the patient, choice of the adequate treatment that combine efficiency, safety and prevent toxic effect.
